05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Nutritional supplements; Dietary and nutritional supplements; Nutritional supplements in the form of capsules, extracts, and gummies; Dietary and nutritional supplements containing mushrooms, mushroom extracts, and/or mycelium extracts; Dietary and nutritional supplements for fortifying the immune system; Beverages containing mushrooms, mushroom extracts, and/or mycelium extracts for use as a nutritional supplement
A bee feeding apparatus having labyrinthine passages. The apparatus is useful for dispensing water, bee feeding supplements, or treatments to wild or domesticated bees. The circuitous entryway hinders or inhibits other insects such as wasps, hornets, or yellow jackets from entering the innermost regions of the feeder and accessing the bee feeding supplements.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary supplements; Nutritional supplements; Vitamin supplements; Nutritional supplements in the form of gummies; Dietary and nutritional supplements containing mushrooms, mushroom extracts, and/or mycelium extracts; Dietary and nutritional supplements for fortifying the immune system
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary supplements in the form of capsules and gummies, powders and liquid extracts; Dietary and nutritional supplements containing mushroom mycelium, botanicals, and vitamin and mineral isolates of the same; Dietary and nutritional supplements
8.
TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH
Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients. In another aspect, tryptamine compositions described herein enhance neuroplasticity by promoting neuronal branching through the formation of neurites (i.e., neurite outgrowth) and neurite elongation (i.e., increasing neurite length).
Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients. In another aspect, tryptamine compositions described herein enhance neuroplasticity by promoting neuronal branching through the formation of neurites (i.e., neurite outgrowth) and neurite elongation (i.e., increasing neurite length).
Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients. In another aspect, tryptamine compositions described herein enhance neuroplasticity by promoting neuronal branching through the formation of neurites (i.e., neurite outgrowth) and neurite elongation (i.e., increasing neurite length).
Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients. In another aspect, tryptamine compositions described herein enhance neuroplasticity by promoting neuronal branching through the formation of neurites (i.e., neurite outgrowth) and neurite elongation (i.e., increasing neurite length).
Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients. In another aspect, tryptamine compositions described herein enhance neuroplasticity by promoting neuronal branching through the formation of neurites (i.e., neurite outgrowth) and neurite elongation (i.e., increasing neurite length).
Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients.
Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients.
Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients.
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
Described herein are fungal compound compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect, the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof, optionally combined with one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum), or combinations thereof, optionally one or more adversive compounds, optionally one or more monoamine oxidase inhibitor (MAOI) compounds, and optionally one or more pharmaceutically acceptable excipients.
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Dietary and nutritional supplements containing mushroom in powdered form for general health and well-being; dietary and nutritional supplements for general health and well being; dietary and nutritional supplements containing mushroom-mycelium powder, vitamin B3 powder, and vitamin B12 powder for general health and well being; vitamin supplements.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary supplements; Dietary supplements consisting primarily of mushroom powders, extracts, and products; Dietary supplements in the form of powders and extracts; Nutritional supplements; Nutritional supplements consisting primarily of mushroom powders, extracts, and products
20.
COMBINED FUNGAL COMPOSITION FOR MODULATING AN INFLAMMATORY RESPONSE
Described herein are combined fungal compositions for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that causes an inflammatory response. In one aspect the composition comprises an aqueous or solid fraction of Trametes versicolor and Fomitopsis officinalis mycelium, fermented substrates thereof, or combinations thereof.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary supplements in the form of powders; Dietary and nutritional supplements; Dietary and nutritional supplements containing mushroom-mycelium powder, vitamin B3 powder, and vitamin B12 powder; Vitamin supplements
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Nutritional supplements in the form of powder; Dietary and nutritional supplements; Dietary and nutritional supplements containing mushroom mycelium powder, protein powder, herbal powders, and vitamin powders
23.
Methods for treating or reducing susceptibility of bees to infection with a bee feeder having labyrinthine passages
Described herein are methods for treating or reducing susceptibility of bees for mites in an ecosystem on bees in an ecosystem with a bee feeding apparatus having labyrinthine passages. The apparatus is useful for dispensing water, bee feeding supplements, or treatments to wild or domesticated bees. The circuitous entryway hinders or inhibits other insects such as wasps, hornets, or yellow jackets from entering the innermost regions of the feeder and accessing the bee feeding supplements. The method includes providing a bee feeding medium to the apparatus, providing the apparatus to an ecosystem, and exposing bees to the bee feeding medium in the apparatus.
Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mycelium, a fermented substrate thereof, or a combination thereof optionally combined with one or more buffering agents, ethanol, and water.
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
A61P 31/14 - Antiviraux pour le traitement des virus ARN
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
05 - Produits pharmaceutiques, vétérinaires et hygièniques
30 - Aliments de base, thé, café, pâtisseries et confiseries
Produits et services
Nutritional supplements; powdered nutritional supplement drink mix Powdered coffee; powdered coffee also containing mushrooms, mycelium, or extracts thereof; instant coffee; instant coffee containing mushrooms, mycelium, or extracts thereof; mixes in the nature of powders for use in the preparation of coffee-based beverages; mixes in the nature of powders for use in the preparation of coffee-based beverages also containing mushrooms, mycelium, or extracts thereof; mixes in the nature of powders for use in the preparation of tea-based beverages; mixes in the nature of powders for use in the preparation of tea-based beverages also containing mushrooms, mycelium, or extracts thereof; hot chocolate mixes; hot chocolate mixes also containing mushrooms, mycelium, or extracts thereof; cocoa mixes; cocoa mixes also containing mushrooms, mycelium, or extracts thereof
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
Described herein are fungal compound compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect, the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof, optionally combined with one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum), or combinations thereof, optionally one or more adversive compounds, optionally one or more monoamine oxidase inhibitor (MAOI) compounds, and optionally one or more pharmaceutically acceptable excipients.
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
33.
FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION
HericiumH. erinaceus, H. coralloides, H. ramosumH. erinaceus, H. coralloides, H. ramosum), or combinations thereof, optionally one or more adversive compounds, optionally one or more monoamine oxidase inhibitor (MAOI) compounds, and optionally one or more pharmaceutically acceptable excipients.
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
A method for monitoring bee populations in an ecosystem by monitoring and recording bee visits to a bee feeding apparatus having labyrinthine passages. The bee feeding apparatus is configured to count and monitor bee visits to the feeder and transmit the bee visit data via one or more communication devices, thus providing an estimate of the economic and ecological benefit of a bee population in an ecosystem. The bee feeding apparatus is useful for dispensing water, bee feeding supplements, or treatments to wild or domesticated bees. The circuitous entryway hinders or inhibits other insects such as wasps, hornets, or yellow jackets from entering the innermost regions of the feeder and accessing the bee feeding supplements.
Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mycelium, a fermented substrate thereof, or a combination thereof optionally combined with one or more buffering agents, ethanol, and water.
Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mycelium, a fermented substrate thereof, or a combination thereof optionally combined with one or more buffering agents, ethanol, and water.
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
A61P 31/14 - Antiviraux pour le traitement des virus ARN
43.
COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSE
Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mushroom mycelium and/or fruit body mixture, optionally combined with one or more buffering agents, ethanol, and water.
Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mushroom mycelium and/or fruit body mixture, optionally combined with one or more buffering agents, ethanol, and water.
Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mycelium, a fermented substrate thereof, or a combination thereof optionally combined with one or more buffering agents, ethanol, and water.
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
09 - Appareils et instruments scientifiques et électriques
36 - Services financiers, assurances et affaires immobilières
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
(1) Cryptocurrency hardware wallets; downloadable computer software for use as a cryptocurrency wallet; downloadable computer software for managing and verifying cryptocurrency transactions on a blockchain; downloadable software for generating cryptographic keys for receiving and spending cryptocurrency; downloadable computer software for managing cryptocurrency transactions using blockchain technology; downloadable computer software for managing and validating cryptocurrency transactions using blockchain-based smart contracts; computer hardware for cryptocurrency mining; downloadable computer software for managing and verifying cryptocurrency transactions on a blockchain; downloadable computer software for managing and verifying nonfungible token transactions on a blockchain; downloadable computer software for managing nonfungible token transactions on a blockchain; downloadable computer software for managing cryptocurrency transactions using blockchain technology; downloadable computer software for accessing, reading, and tracking information in the field of digital assets, namely, nonfungible tokens on a blockchain. (1) Cryptocurrency payment processing; cryptocurrency trading services; cryptocurrency exchange services; financial consultation in the field of cryptocurrency and nonfungible tokens; providing financial information in the field of cryptocurrency and nonfungible tokens; cryptocurrency and nonfungible token exchange services featuring blockchain technology; issuance of tokens of value; issuance of nonfungible tokens; blockchain-based payment verification services; nonfungible token payment processing; nonfungible token trading services; nonfungible token exchange services.
(2) Technological consulting in the field of cryptocurrency and nonfungible tokens; electronic storage of cryptocurrency and nonfungible tokens for others; providing technology information in the field of cryptocurrency and nonfungible tokens; providing on-line non-downloadable computer software for use as a cryptocurrency wallet; providing user authentication services using blockchain-based software technology for cryptocurrency and nonfungible token transactions; providing a website featuring technology that enables users to generate printable cryptocurrency wallets; providing on-line non-downloadable software for generating cryptographic keys for receiving and spending cryptocurrency; providing temporary use of non-downloadable web-based decentralized applications (dapps) for cryptocurrency trading and payment processing, cloud storage of data, and web browsing; providing user authentication services using blockchain-based software technology for cryptocurrency and nonfungible token transactions; authentication of data in the field of ownership of digital assets, namely, nonfungible tokens using blockchain technology; providing temporary use of on-line non-downloadable software for accessing, reading, and tracking information in the field of digital assets, namely, nonfungible tokens on a blockchain.
09 - Appareils et instruments scientifiques et électriques
36 - Services financiers, assurances et affaires immobilières
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Cryptocurrency hardware wallets; downloadable computer software for use as a cryptocurrency wallet; downloadable computer software for managing and verifying cryptocurrency transactions on a blockchain; downloadable software for generating cryptographic keys for receiving and spending cryptocurrency; downloadable computer software for managing cryptocurrency transactions using blockchain technology; downloadable computer software for managing and validating cryptocurrency transactions using blockchain-based smart contracts; computer hardware for cryptocurrency mining; downloadable computer software for managing and verifying nonfungible token transactions on a blockchain; downloadable computer software for managing nonfungible token transactions on a blockchain; downloadable computer software for accessing, reading, and tracking information in the field of digital assets, namely, nonfungible tokens on a blockchain. Cryptocurrency payment processing; cryptocurrency trading services; cryptocurrency exchange services; financial consultation in the field of cryptocurrency and nonfungible tokens; providing financial information in the field of cryptocurrency and nonfungible tokens; cryptocurrency and nonfungible token exchange services featuring blockchain technology; issuance of tokens of value; issuance of nonfungible tokens; blockchain-based payment verification services; nonfungible token payment processing; nonfungible token trading services; nonfungible token exchange services. Technological consulting in the field of cryptocurrency and nonfungible tokens; electronic storage of cryptocurrency and nonfungible tokens for others; providing technology information in the field of cryptocurrency and nonfungible tokens; providing on-line non-downloadable computer software for use as a cryptocurrency wallet; providing user authentication services using blockchain-based software technology for cryptocurrency and nonfungible token transactions; providing a website with technology that enables users to generate printable cryptocurrency wallets; providing on-line non-downloadable software for generating cryptographic keys for receiving and spending cryptocurrency; providing temporary use of non-downloadable web-based decentralized applications (dapps) for cryptocurrency trading and payment processing, cloud storage of data, and web browsing; authentication of data in the field of ownership of digital assets, namely, nonfungible tokens using blockchain technology; providing temporary use of on-line non-downloadable software for accessing, reading, and tracking information in the field of digital assets, namely, nonfungible tokens on a blockchain.
50.
TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH
Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
(1) Dermatological pharmaceutical products; Pharmaceutical skin lotions; Digestives for pharmaceutical purposes; Pharmaceutical preparations; Pharmaceutical preparations for skin care; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical products for the treatment and prevention of disease; Nutraceuticals for use as a dietary supplement; Nutraceuticals for the treatment and prevention of disease; Dietary supplements; Dietary and nutritional supplements; Therapeutic pharmaceutical for the treatment of disease; Therapeutic pharmaceutical for the treatment of mental health disorders; Therapeutic preparations; Extracts for pharmaceutical purposes; Herbal extracts for pharmaceutical purposes; Mushroom extracts for pharmaceutical purposes; Fungal extracts for pharmaceutical purposes; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Topical anesthetics; Topical analgesics; Topical analgesic creams; Topical gel for medical and therapeutic treatments (1) Pharmaceutical research services; Pharmaceutical research and development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines
05 - Produits pharmaceutiques, vétérinaires et hygièniques
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
(1) Dermatological pharmaceutical products; Pharmaceutical skin lotions; Digestives for pharmaceutical purposes; Pharmaceutical preparations; Pharmaceutical preparations for skin care; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical products for the treatment and prevention of disease; Nutraceuticals for use as a dietary supplement; Nutraceuticals for the treatment and prevention of disease; Dietary supplements; Dietary and nutritional supplements; Therapeutic pharmaceutical for the treatment of disease; Therapeutic pharmaceutical for the treatment of mental health disorders; Therapeutic preparations; Extracts for pharmaceutical purposes; Herbal extracts for pharmaceutical purposes; Mushroom extracts for pharmaceutical purposes; Fungal extracts for pharmaceutical purposes; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Topical anesthetics; Topical analgesics; Topical analgesic creams; Topical gel for medical and therapeutic treatments (1) Pharmaceutical research services; Pharmaceutical research and development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
The present invention is based on a plurality of benefits from the extracts of mycelia of individual fungal species, and mixtures of species, to provide an armamentarium of defenses from multiple stressors in order to help bees survive a complex of symptoms collectively called colony collapse disorder (CCD). More particularly, the present invention utilizes specific concentrations of extracts from pure cultured mycelium from mushroom forming fungi to reduce harmful viruses in bees and to increase the longevity of bees.
A23K 50/90 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les insectes, p. ex. pour les abeilles ou les vers à soie
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A01K 51/00 - Dispositifs pour l'entretien des ruches ou de leurs éléments, p. ex. pour leur nettoyage ou leur désinfection
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Nutritional supplements; nutritional supplements, namely, mushroom powders and products for fortifying the immune system; nutritional supplements in liquid form.
Described herein is a bee feeding apparatus having a labyrinthine portal. The apparatus is useful for dispensing water, bee feeding supplements, or treatments to wild or domesticated bees. The circuitous entry way hinders or inhibits other insects such as wasps, hornets, or yellow jackets from entering the innermost regions of the feeder and accessing the bee feeding supplements.
A bee feeding apparatus having labyrinthine passages. The apparatus is useful for dispensing water, bee feeding supplements, or treatments to wild or domesticated bees. The circuitous entryway hinders or inhibits other insects such as wasps, hornets, or yellow jackets from entering the innermost regions of the feeder and accessing the bee feeding supplements.
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
29 - Viande, produits laitiers et aliments préparés ou conservés
Produits et services
Soup mixes; soup mixes containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; soup pastes; soup pastes containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; soup broth; soup broth containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; soup cubes; soup cubes containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; soup concentrates; soup concentrates containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; vegetable soup preparations; vegetable soup preparations containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; matzo ball soup; matzo ball soup containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; pre-cooked soup; pre-cooked soup containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; preparations for making soup; preparations for making soup containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; mixes for making soup; mixes for making soup containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; instant or pre-cooked soup; instant or pre-cooked soup containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; instant or pre-cooked miso soup; instant or pre-cooked miso soup containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; combination meal consisting primarily of a meat or vegetable-based entree and a soup or salad for consumption on or off the premises; combination meal consisting primarily of a meat or vegetable- based entree and a soup or salad for consumption on or off the premises containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; soups; soups containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; soups and preparations for making soups; soups and preparations for making soups containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; drinkable soups; drinkable soups containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; extracts for soups; extracts for soups containing extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof; prepared entrees consisting primarily of vegetables, soups, fruit salads and vegetable salads; prepared entrees consisting primarily of vegetables, soups, fruit salads and vegetable salads containing mushroom primordia or mushroom mycelium or mushroom myceliated substrates or mushroom fruitbodies or extract of mushroom mycelium or extract of mushroom myceliated substrates or extract of mushroom fruitbodies or combinations thereof
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary supplements in the form of capsules and extracts; capsules containing mushroom mycelium dietary supplements and herbal dietary supplements; dietary supplement capsules containing mushrooms and herbs; dietary supplement capsules containing mushrooms combined with extract of herbs; dietary supplement capsules containing mushrooms combined with extract of botanicals; dietary supplement capsules containing mushroom mycelium combined with herbs; dietary supplement capsules containing mushroom mycelium combined with extract of herbs; dietary supplement capsules containing mushroom mycelium combined with extract of botanicals; dietary supplement capsules containing myceliated substrates combined with herbs; dietary supplement capsules containing myceliated substrates combined with extract of herbs; dietary supplement capsules containing myceliated substrates combined with extract of botanicals; extract containing mushroom mycelium dietary supplements and herbal dietary supplements in the nature of dietary supplements; extract containing extract of mushrooms combined with herbs in the nature of dietary supplements; extract containing extract of mushrooms combined with extract of herbs in the nature of dietary supplements; extract containing extract of mushrooms combined with extract of botanicals in the nature of dietary supplements; extract containing extract of mushroom mycelium combined with herbs in the nature of dietary supplements; extract containing extract of mushroom mycelium combined with extract of herbs in the nature of dietary supplements; extract containing extract of mushroom mycelium combined with extract of botanicals in the nature of dietary supplements; extract containing extract of myceliated substrates combined with herbs in the nature of dietary supplements; extract containing extract of myceliated substrates combined with extract of herbs in the nature of dietary supplements; extract containing extract of myceliated substrates combined with extract of botanicals in the nature of dietary supplements
The present invention is based on a plurality of benefits from the extracts of mycelia of individual fungal species, and mixtures of species, to provide an armamentarium of defenses from multiple stressors in order to help bees survive a complex of symptoms collectively called colony collapse disorder (CCD). More particularly, the present invention utilizes specific concentrations of extracts from pure cultured mycelium from mushroom forming fungi to reduce harmful viruses in bees and to increase the longevity of bees.
A23K 20/147 - Dérivés polymériques, p. ex. peptides ou protéines
A23K 20/158 - Acides grasGraissesProduits contenant des huiles ou des graisses
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
Phenyl carboxylate/acrylate compounds having unique antiviral properties found in mushroom mycelium and their analogs are extracted, concentrated, isolated, synthesized or manufactured to create compositions useful in treating, ameliorating, mitigating, alleviating, reducing or curing a pathogenic virus infection such as human papilloma virus. More particularly, such compositions can include one or more of syringic acid, trans-cinnamic acid, trans-ferulic acid, salts thereof or esters thereof. The compositions can be formulated into dosage forms comprising sprays, capsules, tablets, elixirs, emulsions, lozenges, suspensions, syrups, pills, lotions, epidermal patches, suppositories, inhalers, or injectables.
A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p. ex. leucoglucosane, hespéridine, érythromycine, nystatine
Compounds having unique antiviral properties found in mushroom mycelium and their analogs are extracted, concentrated, isolated or manufactured to create compositions useful in preventing the spread and proliferation of various viruses afflicting animals, particularly viruses harming humans, pigs, birds, bats and bees. Such compounds and compositions can be used individually or in combination with known medicines or natural products to improve health.
A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
A61K 31/352 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à six chaînons avec un oxygène comme seul hétéro-atome d'un cycle condensés avec des carbocycles, p. ex. cannabinols, méthanthéline
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p. ex. leucoglucosane, hespéridine, érythromycine, nystatine
The present invention provides a plurality of benefits from the extracts of mycelia of individual fungal species, and mixtures of species, to provide an armamentarium of defenses from multiple stressors in order to help bees survive a complex of symptoms collectively called colony collapse disorder (CCD). More particularly, the present invention utilizes specific concentrations of extracts from pure cultured mycelium from mushroom forming fungi to reduce harmful viruses in bees and to increase the longevity of bees.
A01K 51/00 - Dispositifs pour l'entretien des ruches ou de leurs éléments, p. ex. pour leur nettoyage ou leur désinfection
A23K 10/16 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires
A23K 20/00 - Éléments nutritifs accessoires pour produits alimentaires pour animaux
41 - Éducation, divertissements, activités sportives et culturelles
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
[educational services, namely conducting, classes, seminars, workshops relating to mushroom cultivation] mail order services [and distributorships;both] featuring mushroom cultivation products; and research and consultation; both relating to mushroom cultivation
41 - Éducation, divertissements, activités sportives et culturelles
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
[educational services, namely, conducting, classes, seminars, workshops relating to mushroom cultivation] mail order services [and distributorships; both] featuring mushroom cultivation products; and research and consultation; both relating to mushroom cultivation
